Stem cell transplant options for patients without a perfect match
Part of Blood & lymphatic, Brain & nervous system, Cancer, Genetic & congenital, Hormones & metabolism, Immune system & allergy clinical trials.
This trial offers a stem cell transplant using a half-matched family donor and/or cord blood for people with high-risk or hard-to-treat cancers or blood disorders. It aims to provide a treatment option when a perfectly matched donor is not available.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a family member (parent, child, or sibling) who is at least half-matched as a stem cell donor.
- You have at least one cord blood unit (banked) that matches you at 4 out of 6 key markers, or two that together provide enough cells.
- Age: You are under 65 years old.
- You have a high-risk or relapsed cancer, or a blood disorder that can be treated with a stem cell transplant.
- Your doctor confirms you are healthy enough for a stem cell transplant.
- You do not have a fully matched related or unrelated donor available.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial uses a stem cell transplant from a partially matched family member or unrelated donor to treat cancer and other blood disorders. Because the donor isn't fully matched, the transplant uses a special method to select certain stem cells (CD34-selected) to help reduce complications.
This trial provides a special type of stem cell transplant for people under 22 years old who don't have a fully matched sibling donor. It uses a method to remove certain cells from the donor's stem cells to reduce the risk of graft-versus-host disease, where the donor cells attack the patient's body.
This trial tests a stem cell transplant from a family donor whose tissue type is only partly matched, for adults with blood cancers who don't have a fully matched sibling or other closely matched donor. The goal is to make transplant possible for more patients.
This study tests a special stem cell transplant for children and young adults with certain high-risk blood cancers or bone marrow diseases. It uses a half-matched family donor and a technique to remove specific cells, which may lower the risk of side effects and help the body accept the new cells.
This expanded-access study offers a specific type of stem cell transplant preparation that removes certain immune cells (CD3 and CD19) from donor stem cells. It is for children who need a transplant but do not have a fully matched sibling donor and whose team cannot use the hospital’s usual matching device protocol.
This trial studies a type of stem cell transplant (bone marrow transplant) that uses a donor who is only half-matched to the patient, often a parent or sibling. It is for children and young adults with certain blood diseases, including sickle cell disease, thalassemia, bone marrow failure, and immune disorders. The transplant aims to replace the diseased blood-forming cells with healthy ones from the donor.
Hear when a new Hematologic Malignancies trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.